Start Free, Stay Free, AIDS Free is a unified framework to end vertical HIV transmission, cut new infections among adolescents and young women, and increase and sustain access to antiretroviral treatment (ART) by children and adolescents. EGPAF is supporting efforts to reach the ambitious targets associated with the framework including ending new infections in children.
The UNAIDS "90-90-90" targets aim for 90% of all children living with HIV to be diagnosed, 90% of those diagnosed HIV-positive receiving treatment, and 90% of those children receiving treatment achieving viral suppression by 2020.
Our briefing document illustrates what is needed to reach the UNAIDS Fast Track Targets for children. A new “Super Fast-Track” target of putting 95% of children on treatment by 2018 means these steps are even more vital.
This document discusses why action must be taken at all levels to expand pediatric services in facilities and commuities and to initiate and retain children in these vital programs.
As a result of collaborative advocacy efforts between EGPAF and other non-governmental organizations, UNAIDS produced a gap analysis on pediatric HIV treatment in December 2014, and an updated gap analysis in December 2016. Both reports were accompanied by a set of decisions by the UNAIDS Programme Coordinating Board on ways to promote better progress on pediatric treatment. EGPAF works closely with UNAIDS to address access to treatment for children living with HIV including by ensuring the UNAIDS Strategy 2016-2021 included strong and comprehensive language on addressing the pediatric treatment gap.
Our briefing document highlights the numerous problems with currently available ARV formulations for children, which can be unpalatable, difficult to swallow, and hard to administer, and identifies areas where additional research and innovation is needed.
On 17 November 2017, key stakeholders met to discuss how to address these issues with due urgency. They agreed on an Action Plan made up of over 30 commitments to focus, accelerate, and collaborate on the development, registration, introduction, and roll-out of the most optimal pediatric formulations and diagnostics
EGPAF partnered with the Inter-Parliamentary Union on a paper addressing the challenges of pediatric HIV treatment and highlighting what parliamentarians can do to help further the agenda in their country.
From June 8-10, 2016, The United Nations held a High Level Meeting (HLM) on HIV and AIDS where UN Member States adopted a political declaration on the global HIV epidemic that includes ambitious pediatric treatment and EMTCT targets and other political commitments in support of ending AIDS in children. Leading up to this meeting EPGAF advocated for the inclusion of such strong language and targets by being a panelist in an Informal Civil Society Hearing at the UN in New York in April 2016, and a Panel on Children, Adolescents, and Young Women at the HLM, as well as through extensive engagement with governments. EGPAF made a statement at the June 2016 UNAIDS Programme Coordinating Board Meeting in Geneva highlighting the important outcomes on children and adolescents from the High Level Meeting and the need to take action on these commitments.
EGPAF continues to have a close collaboration with the Organization of African First Ladies against HIV/AIDS (OAFLA) to accelerate progress in eliminating new HIV infections among children, adolescents and women by 2020. The current partnership focuses on raising the capacity of First Ladies and their Technical Advisors to advocate on elimination of mother-to-child transmission of HIV (EMTCT), pediatric HIV treatment, adolescents and HIV as well as linking the work of African First Ladies to global initiatives and structures, such as Start Free Stay Free AIDS. This wok will include support and monitoring visits to enhance the impact that the First Ladies have in country and the sub-regions. To see previous toolkit click here. The new toolkit will be launched in January 2018 and will help to facilitate the achievement of the goals that OAFLA put forward in its strategic plan for 2014-2018 and to reach the goals set out by the African Union’s EMTCT campaign.
From June 8-10, 2016, The United Nations held a High Level Meeting (HLM) on HIV and AIDS where UN Member States adopted a political declaration on the global HIV epidemic that includes ambitious pediatric treatment and EMTCT targets and other political commitments in support of ending AIDS in children. Leading up to this meeting EPGAF advocated for the inclusion of such strong language and targets by being a panelist in an Informal Civil Society Hearing at the UN in New York in April 2016, and a Panel on Children, Adolescents, and Young Women at the HLM, as well as through extensive engagement with governments. EGPAF made a statement at the recent UNAIDS Programme Coordinating Board Meeting in Geneva highlighting the important outcomes on children and adolescents from the High Level Meeting and the need to take action on these commitments.
The African Union created AIDS Watch Africa as a political advocacy platform to more directly engage African Heads of States in TB, HIV and malaria on the continent. As a member of the AWA Consultative Experts Committee, EGPAF is involved in generating documentation for consideration by the AWA Heads of State and Government, conducting advocacy and networking with partners in and outside Africa, and following up on implementation of the recommendations of the AWA Action Committee.
The objective of the Catalytic Framework is to intensify implementation of the Abuja +12 commitments on HIV, TB and Malaria by building Africa-wide consensus on key strategic actions within the context of the existing targets and milestones. It takes into account the Sustainable development goals (SDGs) and the 2016 United Nations Political Declaration on Ending HIV and AIDS. EGPAF continues to work closely with AIDS Watch Africa (AWA) to ensure that children are prioritized in the response by the African Union and the member states. EGPAF is a member of the AWA steering committee that has consultative status to provide the AWA Heads of States and Governments with expertise and counsel in implementing their mandate to lead advocacy, accountability and resource mobilization efforts to respond to TB, HIV and Malaria.
The U.S. is the single largest funder of HIV/AIDS activities around the world. EGPAF advocates on Capitol Hill and to the Administration for a strong bi-lateral global HIV/AIDS response through PEPFAR, USAID and CDC, as well as multilateral commitments through the Global Fund to Fight AIDS, Tuberculosis and Malaria.Protect Global Health & Development Funding
EGPAF has been advocating with major donors like The Global Fund and PEPFAR for increased prioritization of pediatric HIV prevention and treatment in their funding allocations. An analysis of the last Global Fund funding cycle demonstrated insufficient support for EMTCT and pediatric HIV treatment.
New HIV infections in children in the United States have dramatically declined since the beginning of the epidemic—infections in children peaked in 1992 when there were approximately 2,000 new pediatric HIV cases per year. Today there are only about 100-200 new infections in children each year. EGPAF advocates to ensure that new infections in children remain low and that pregnant women and children infected with HIV have access to the critical services and medicines they need to survive and thrive.Read More
Since its inception, EGPAF has advocated for children to be included in and benefit from scientific advances in HIV treatment and prevention. The National Institute of Health (NIH) is the worldwide leader in HIV research and its work to combat pediatric HIV and AIDS is crucial to ensuring that children impacted by the disease survive and thrive. EGPAF regularly engages with NIH to keep pediatric AIDS research a priority and pushes Congress to sufficiently fund promising HIV research. Read EGPAF CEO’s recent letter advocating for the important work of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network.
The Ryan White HIV/AIDS Program provides critical services to women and children impacted by HIV in the United States, particularly for the approximately 8,500 HIV positive pregnant women each year who need tailored care to ensure HIV is not transmitted to their children. This is why the Foundation continues to advocate for Ryan White programs as a critical part of the U.S. HIV service continuum, particularly supporting Ryan White Part D which addresses the medical and non-medical needs of women, infants, children, youth and families living with and impacted by HIV and AIDS.
Children are not just small adults, and children being treated for HIV, or any disease, should have drugs that are labeled and formulated specifically for them. EGPAF works with Congress and the Food and Drug Administration (FDA) on pediatric drug laws and programs to ensure that new medicines, vaccines and devices take into account the unique needs of children.
The Every Woman Every Child movement was launched in 2010 to build support for the United Nation’s Secretary General’s Global Strategy for Women’s and Children’s Health and has since redoubled its efforts in support of the updated Global Strategy on Women’s, Children’s, and Adolescent’s Health that was launched in September of 2015. In addition to helping mobilize and intensify global action around maternal and child health, the Foundation is directly contributing to the objectives of EWEC through its commitment to work with governments to improve access to life-long ART through maternal, newborn, and child health (MNCH) services over the next several years.
The Campaign on Accelerated Reduction of Maternal Mortality in Africa (CARMMA) was initiated by the African Union Commission to address the challenges of maternal mortality in African countries and launched in 2009. EGPAF supports this initiative through its strong collaboration with the African Union and advocating for evidence-based innovations and best practices to reduce maternal mortality.
This document presents key facts about the impact HIV/AIDS has on children and outlines the important steps of preventing mother-to-child transmission of HIV.Read More
Sign up for email updates
Lend Your Voice